CENTOGENE N.V.

CNTG
Delayed Quote. Delayed  - 07/28 04:00:00 pm
11.48USD -0.95%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 193257
Entreprise Value (EV)2 148244
P/E ratio -8,65x-9,00x
Yield --
Capitalization / Revenue 1,50x1,79x
EV / Revenue 1,15x1,69x
EV / EBITDA 136x-19,0x
Price to Book 2,81x5,24x
Nbr of stocks (in thousands) 21 86122 423
Reference price (EUR) 8,8311,5
Announcement Date 04/15/2021-
Previous period Next period
1 USD in Million
2 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 128144
EBITDA1 1,08-12,8
Operating profit (EBIT)1 -19,7-27,5
Operating Margin -15,3%-19,1%
Pre-Tax Profit (EBT)1 -21,1-28,3
Net income1 -21,4-28,3
Net margin -16,7%-19,7%
EPS2 -1,02-1,28
Dividend per Share2 --
Announcement Date 04/15/2021-
Previous period Next period
1 EUR in Million
2 EUR
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 45,313,7
Leverage (Debt / EBITDA) -41,8x1,07x
Free Cash Flow1 -1,04-16,3
ROE (Net Profit / Equities) -34,1%-60,5%
Shareholders' equity1 62,846,8
ROA (Net Profit / Asset) -16,0%-25,1%
Assets1 134113
Book Value Per Share2 3,142,19
Cash Flow per Share2 0,40-0,17
Capex1 9,5011,0
Capex / Sales 7,40%7,67%
Announcement Date 04/15/2021-
Previous period Next period
1 EUR in Million
2 EUR
Financial Ratios
Size 2021e 2022e
Capitalization 257 M € -
Entreprise Value (EV) 244 M € 250 M €
Valuation 2021e 2022e
P/E ratio (Price / EPS) -9,00x -7,78x
Capitalization / Revenue 1,79x 3,85x
EV / Revenue 1,69x 3,64x
EV / EBITDA -19,0x -17,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 5,24x 4,22x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -19,1% -52,4%
Operating Leverage (Delta EBIT / Delta Sales) - -0,51x
Net Margin (Net Profit / Revenue) -19,7% -52,4%
ROA (Net Profit / Asset) -25,1% -34,0%
ROE (Net Profit / Equities) -60,5% -61,5%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   7,67% 13,3%
Cash Flow / Sales -2,65% -9,56%
Capital Intensity (Assets / Sales) 0,78x 1,54x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend